Innovative Targeting Solutions Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Innovative Targeting Solutions Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11329
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Innovative Targeting Solutions Inc (ITS) is an antibody generation company that discovers and develops novel human monoclonal antibody technologies. The company develops a next generation protein engineering platform that helps for the generation of fully human antibody and T cell receptor based therapeutics using its proprietary HuTARG technology. Its HuTARG technology is a protein engineering platform that generates large repertoires of fully human antibodies or other protein-based drug modalities, in a mammalian cell host for the first time. It utilizes its technology to develop its pipeline programs such as agonists, rare epitopes, and complex membrane proteins for various therapeutic areas. The company partners with pharmaceutical companies to identify specific target classes and therapeutic indications. ITS is headquartered in Vancouver, British Columbia, Canada.

Innovative Targeting Solutions Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Innovative Targeting Solutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Innovative Targeting Solutions Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Innovative Targeting Solutions Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Innovative Targeting Solutions Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Innovative Targeting Solutions Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Innovative Targeting Solutions Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Innovative Targeting Solutions Raises Funds in Series A Financing Round 10
Partnerships 11
Innovative Targeting Solutions Enters into Research Agreement with Sanofi 11
Innovative Targeting Solutions Enters into Research Agreement with Eli Lilly 12
Innovative Targeting Solutions Enters into Research Agreement with Janssen Biotech 13
Innovative Targeting Solutions Enters into Research Agreement with Merck 14
Innovative Targeting Solutions Enters into Research Agreement with Amgen 15
Licensing Agreements 16
Zymeworks Enters into Licensing Agreement with Innovative Targeting Solutions 16
Innovative Targeting Solutions Inc – Key Competitors 17
Innovative Targeting Solutions Inc – Key Employees 18
Innovative Targeting Solutions Inc – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Innovative Targeting Solutions Inc, Pharmaceuticals & Healthcare, Key Facts 2
Innovative Targeting Solutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Innovative Targeting Solutions Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Innovative Targeting Solutions Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Innovative Targeting Solutions Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Innovative Targeting Solutions Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Innovative Targeting Solutions Raises Funds in Series A Financing Round 10
Innovative Targeting Solutions Enters into Research Agreement with Sanofi 11
Innovative Targeting Solutions Enters into Research Agreement with Eli Lilly 12
Innovative Targeting Solutions Enters into Research Agreement with Janssen Biotech 13
Innovative Targeting Solutions Enters into Research Agreement with Merck 14
Innovative Targeting Solutions Enters into Research Agreement with Amgen 15
Zymeworks Enters into Licensing Agreement with Innovative Targeting Solutions 16
Innovative Targeting Solutions Inc, Key Competitors 17
Innovative Targeting Solutions Inc, Key Employees 18

List of Figures
Innovative Targeting Solutions Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Innovative Targeting Solutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Innovative Targeting Solutions Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Innovative Targeting Solutions Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Innovative Targeting Solutions Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Innovative Targeting Solutions Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Innovative Targeting Solutions Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Innovative Targeting Solutions Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Innovative Targeting Solutions Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Codan Radio Communications:企業の戦略・SWOT・財務情報
    Codan Radio Communications - Strategy, SWOT and Corporate Finance Report Summary Codan Radio Communications - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Business Development Bank of Canada:企業のM&A・事業提携・投資動向
    Business Development Bank of Canada - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Business Development Bank of Canada Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on …
  • Paliburg Holdings Limited:戦略・SWOT・企業財務分析
    Paliburg Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Paliburg Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Glidewell Laboratories:企業の戦略的SWOT分析
    Glidewell Laboratories - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • U.S. Army Institute of Surgical Research:医療機器:M&Aディール及び事業提携情報
    Summary U.S. Army Institute of Surgical Research (USAISR), a subsidiary of U.S. Army, is a medical research center that offers solutions for burn, trauma, and combat casualty care from time of injury to rehabilitation. The center conducts research in the areas of dental and trauma research detachmen …
  • Electricite du Liban:企業の戦略的SWOT分析
    Electricite du Liban - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Kura Oncology Inc (KURA):製薬・医療:M&Aディール及び事業提携情報
    Summary Kura Oncology Inc (Kura Oncology) is a clinical-stage biopharmaceutical company that discovers and develops therapeutics for the treatment of solid tumors and blood cancers. The company’s lead drug candidate Tipifarnib, an inhibitor of farnesyl transferase, an oral investigational drug candi …
  • CanBas Co Ltd (4575):製薬・医療:M&Aディール及び事業提携情報
    Summary CanBas Co Ltd (CanBas) is a clinical stage biopharmaceutical company that develops therapeutics for cancer. The company discovers and develops of novel therapeutics in the field of oncology targeting the cell cycle. It provides two clinical oncology programs, CBP501 and CBS9106 with mutually …
  • DexCom Inc (DXCM)-医療機器分野:企業M&A・提携分析
    Summary DexCom Inc (DexCom) is a medical device company that performs design, development and commercialization of continuous glucose monitoring systems for ambulatory and in-hospital use. The company’s major products include DexCom G4, DexCom G4 Platinum and other continuous glucose monitoring syst …
  • Crescent Point Energy Corp (CPG):石油・ガス:M&Aディール及び事業提携情報
    Summary Crescent Point Energy Corp (Crescent Point) is an oil and gas company. It acquires, explores, develops and produces light and medium crude oil, heavy crude oil, tight oil, natural gas liquids, shale gas and conventional natural gas. The company holds interest in light and medium oil and natu …
  • PositiveID Corp (PSID):医療機器:M&Aディール及び事業提携情報
    Summary PositiveID Corp (PositiveID), formerly VeriChip Corp is a life sciences tools and diagnostics company that develops biological detection and molecular diagnostic systems. The company develops microfluidic systems for automated preparation and performance of biological assays. Its products in …
  • Polpharma SA-製薬・医療分野:企業M&A・提携分析
    Summary Polpharma SA (Polpharma) undertakes the research, manufacture and marketing of generic drugs, prescription drugs and over the counter medications. It provides drugs in cardiology, gastroenterology and neurology areas. The company also manufactures over the counter (OTC) medications, dietary …
  • Beaver Aerospace & Defense, Inc.:企業の戦略・SWOT・財務情報
    Beaver Aerospace & Defense, Inc. - Strategy, SWOT and Corporate Finance Report Summary Beaver Aerospace & Defense, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Viking Therapeutics Inc (VKTX):企業の財務・戦略的SWOT分析
    Summary Viking Therapeutics Inc (Viking Therapeutics) is a clinical-stage biopharmaceutical company that develops novel therapies for patients suffering from metabolic and endocrine disorders. Its lead clinical program product candidate include VK5211, an orally available, non-steroidal selective an …
  • IBIDEN CO., LTD.:企業の戦略・SWOT・財務情報
    IBIDEN CO., LTD. - Strategy, SWOT and Corporate Finance Report Summary IBIDEN CO., LTD. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Fujirebio Europe NV:企業の戦略的SWOT分析
    Fujirebio Europe NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Ovid Therapeutics Inc (OVID):製薬・医療:M&Aディール及び事業提携情報
    Summary Ovid Therapeutics Inc (Ovid Therapeutics) is a bio-pharmaceutical company which identifies, discovers, and develops medicines for neurological disorders. The company’s pipeline products are indicated for diseases such as Angelman Syndrome and Fragile X Syndrome. It develops, assess, commerci …
  • CH2M HILL Companies, Ltd.:戦略・SWOT・企業財務分析
    CH2M HILL Companies, Ltd. - Strategy, SWOT and Corporate Finance Report Summary CH2M HILL Companies, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Breville Group Ltd (BRG):企業の財務・戦略的SWOT分析
    Breville Group Ltd (BRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • KYORIN Holdings Inc (4569):製薬・医療:M&Aディール及び事業提携情報
    Summary KYORIN Holdings Inc (KYORIN), formerly known as KYORIN Co.,Ltd., is a holding company. Its business activities include controlling, administering and supporting companies, which conduct various businesses by holding the shares of those companies. The company through its subsidiaries carries …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆